 Alnylam Pharmaceuticals IncALNY | $9.9M30.4k shares | Grant / ExerciseMar 2, 2026 | $9.9M30.4k shares | $325.07 | -- |
| Alnylam Pharmaceuticals IncALNY | $33M102.1k shares | SellMar 2, 2026 | $545.4K1.7k shares | $326.81 | -- |
| Alnylam Pharmaceuticals IncALNY | $33M100.7k shares | SellMar 2, 2026 | $458.4K1.4k shares | $327.67 | -- |
| Alnylam Pharmaceuticals IncALNY | $34M103.7k shares | SellMar 2, 2026 | $357.5K1.1k shares | $325.63 | -- |
| Alnylam Pharmaceuticals IncALNY | $33M99.5k shares | SellMar 2, 2026 | $238.1K722 shares | $329.71 | -- |
| Alnylam Pharmaceuticals IncALNY | --105.4k shares | Grant / ExerciseMar 2, 2026 | Disclosure amount unavailable13.8k shares | -- | -- |
| Alnylam Pharmaceuticals IncALNY | --110.7k shares | Grant / ExerciseMar 2, 2026 | Disclosure amount unavailable110.7k shares | -- | -- |
| Alnylam Pharmaceuticals IncALNY | $33M100.3k shares | SellMar 2, 2026 | $139.4K424 shares | $328.71 | -- |
| Alnylam Pharmaceuticals IncALNY | $33M98.8k shares | SellMar 2, 2026 | $132.4K399 shares | $331.93 | -- |
| Alnylam Pharmaceuticals IncALNY | $34M104.8k shares | SellMar 2, 2026 | $124.0K382 shares | $324.65 | -- |
| Alnylam Pharmaceuticals IncALNY | $33M99.2k shares | SellMar 2, 2026 | $114.5K346 shares | $330.85 | -- |
| Alnylam Pharmaceuticals IncALNY | $34M105.2k shares | SellMar 2, 2026 | $64.7K200 shares | $323.62 | -- |
| Alnylam Pharmaceuticals IncALNY | $33M98.6k shares | SellMar 2, 2026 | $53.2K160 shares | $332.64 | -- |
| Alnylam Pharmaceuticals IncALNY | --5.9k shares | Grant / ExerciseFeb 27, 2026 | Disclosure amount unavailable5.9k shares | -- | -- |
| Alnylam Pharmaceuticals IncALNY | $27M85.7k shares | SellFeb 13, 2026 | $2.2M7k shares | $310.08 | -- |
| Alnylam Pharmaceuticals IncALNY | --92.6k shares | Grant / ExerciseFeb 12, 2026 | Disclosure amount unavailable14.2k shares | -- | -- |
| Alnylam Pharmaceuticals IncALNY | $29M80.3k shares | SellJan 12, 2026 | $510.0K1.4k shares | $365.56 | -- |
| Alnylam Pharmaceuticals IncALNY | $30M81.7k shares | SellJan 12, 2026 | $459.3K1.3k shares | $364.83 | -- |
| Alnylam Pharmaceuticals IncALNY | $30M84.3k shares | SellJan 12, 2026 | $353.0K980 shares | $360.22 | -- |
| Alnylam Pharmaceuticals IncALNY | $31M85.8k shares | SellJan 12, 2026 | $278.7K778 shares | $358.18 | -- |
| Alnylam Pharmaceuticals IncALNY | $30M83.7k shares | SellJan 12, 2026 | $225.5K624 shares | $361.45 | -- |
| Alnylam Pharmaceuticals IncALNY | $31M86.6k shares | SellJan 12, 2026 | $216.8K607 shares | $357.17 | -- |
| Alnylam Pharmaceuticals IncALNY | $29M79.1k shares | SellJan 12, 2026 | $215.3K584 shares | $368.62 | -- |
| Alnylam Pharmaceuticals IncALNY | $31M85.3k shares | SellJan 12, 2026 | $192.9K537 shares | $359.14 | -- |
| Alnylam Pharmaceuticals IncALNY | $30M83.2k shares | SellJan 12, 2026 | $168.1K464 shares | $362.38 | -- |
| Alnylam Pharmaceuticals IncALNY | $29M79.9k shares | SellJan 12, 2026 | $115.8K316 shares | $366.41 | -- |
| Alnylam Pharmaceuticals IncALNY | $30M82.9k shares | SellJan 12, 2026 | $109.4K301 shares | $363.55 | -- |
| Alnylam Pharmaceuticals IncALNY | $29M79.7k shares | SellJan 12, 2026 | $95.9K261 shares | $367.40 | -- |
| Alnylam Pharmaceuticals IncALNY | $31M87.5k shares | SellJan 12, 2026 | $95.5K269 shares | $355.16 | -- |
| Alnylam Pharmaceuticals IncALNY | $31M87.2k shares | SellJan 12, 2026 | $93.7K263 shares | $356.09 | -- |
| Alnylam Pharmaceuticals IncALNY | $29M78.9k shares | SellJan 12, 2026 | $93.5K253 shares | $369.48 | -- |
| Alnylam Pharmaceuticals IncALNY | $31M87.7k shares | SellJan 12, 2026 | $87.4K247 shares | $353.95 | -- |
| Alnylam Pharmaceuticals IncALNY | $29M78.5k shares | SellJan 12, 2026 | $44.3K118 shares | $375.65 | -- |
| Alnylam Pharmaceuticals IncALNY | $29M78.7k shares | SellJan 12, 2026 | $43.8K118 shares | $370.87 | -- |
| Alnylam Pharmaceuticals IncALNY | $30M78.4k shares | SellJan 12, 2026 | $35.5K94 shares | $377.82 | -- |
| Alnylam Pharmaceuticals IncALNY | $29M78.6k shares | SellJan 12, 2026 | $33.0K88 shares | $374.44 | -- |
| Alnylam Pharmaceuticals IncALNY | $29M78.7k shares | SellJan 12, 2026 | $7.8K21 shares | $372.46 | -- |
| Alnylam Pharmaceuticals IncALNY | --88k shares | Grant / ExerciseJan 11, 2026 | Disclosure amount unavailable19k shares | -- | -- |